- Research Methods &
- Research Training
- Research Into
|Title||Economic impact of advanced pediatric cancer on families.|
|Publication Type||Journal Article|
|Year of Publication||2014|
|Authors||Bona K, Dussel V, Orellana L, Kang T, Geyer R, Feudtner C, Wolfe J|
|Journal||J Pain Symptom Manage|
|Date Published||2014 Mar|
|Keywords||Adaptation, Psychological, Adult, Child, Cross-Sectional Studies, Family, Female, Humans, Income, Male, Neoplasms, Parents, Poverty, Socioeconomic Factors, United States|
CONTEXT: Despite emerging evidence of substantial financial distress in families of children with complex illness, little is known about economic hardship in families of children with advanced cancer.
OBJECTIVES: To describe perceived financial hardship, work disruptions, income losses, and associated economic impact in families of children with advanced cancer stratified by federal poverty level (FPL).
METHODS: Cross-sectional survey of 86 parents of children with progressive, recurrent, or nonresponsive cancer at three children's hospitals. Seventy-one families with complete income data (82%) are included in this analysis.
RESULTS: Parental work disruptions were prevalent across all income levels, with 67 (94%) families reporting some disruption. At least one parent quit a job because of the child's illness in 29 (42%) families. Nineteen (27%) families described their child's illness as a great economic hardship. Income losses because of work disruptions were substantial for all families; families at or below 200% FPL, however, were disproportionately affected. Six (50%) of the poorest families lost more than 40% of their annual income as compared with two (5%) of the wealthiest families (P = 0.006). As a result of income losses, nine (15%) previously nonpoor families fell from above to below 200% FPL.
CONCLUSION: The economic impact of pediatric advanced cancer on families is significant at all income levels, although poorer families suffer disproportionate losses. Development of ameliorative intervention strategies is warranted.
|Alternate Journal||J Pain Symptom Manage|
|PubMed Central ID||PMC4174345|
|Grant List||1K07 CA096746-01 / CA / NCI NIH HHS / United States |
K07 CA096746 / CA / NCI NIH HHS / United States